Upgrade

TriSalus Life Sciences, Inc.

TLSIW

Last
$0.98
Day
+15.3%
1y
-31.5%
5y
+326.0%
52w
-80.4%
SPY YTD
+13.3%
Sec
—
Earnings
—
EMA 21
0.91
EMA 50
0.91
EMA 200
1.10
20d high
-21.6%
5y high
-80.4%
5y range
18th
Website · 102 employees · United States

Positions held

Your positions

TLSIW isn't in your positions.

Add it to see shares, cost, and P&L here.

Score
9
Hold
watch
Signal
Neutral
Target
$1.21
Stop
$0.79
Stop distance
19.4%
Target vs last
+23.5%

Fundamentals

Market cap—Enterprise value—Trailing P/E—Forward P/E—
PEG—Price / book4.69Beta0.47Dividend yield—
Revenue growth1.7%Earnings growth—Gross margin85.8%Operating margin-86.0%
Profit margin-62.6%ROE—ROA-36.8%Debt / equity5.26
Current ratio5.35Free cash flow-$10.88MAnalyst recommendationnoneMean target—
52w high$1.8552w low$0.44

Quarterly

2026-Q22026-Q12025-Q42025-Q32025-Q22025-Q1
Revenue$11.4M$8.9M$13.2M$11.6M$11.2M—
Op margin-86.0%-94.5%-24.8%-77.9%-65.4%—
Net income-$9.2M$1.5M-$9.8M-$10.8M-$8.3M—
Gross margin86.8%86.2%86.7%83.5%83.9%—
Gross profit$9.9M$7.7M$11.4M$9.7M$9.4M—
Operating income-$9.8M-$8.4M-$3.3M-$9.0M-$7.3M—
  • Revenue +28% vs prior quarter ($11M vs $8.9M).
  • Gross margin 86.8% (was 86.2% prior quarter).
  • Operating margin expanded to -86%.

Yearly (6y)

20252024202320222021
Revenue$45.2M$29.4M$18.5M$12.4M—
Op margin-59.7%-122.9%-294.3%-293.9%—
Net income-$39.2M-$30.0M-$59.4M-$47.2M—
Gross margin84.6%86.1%85.9%81.8%—
Gross profit$38.2M$25.3M$15.9M$10.1M—
Operating income-$26.9M-$36.2M-$54.5M-$36.4M—
Headline scan

No flags

• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).

News

No headlines.

TLSIW · daily+10.1% over 12 sessions
Close EMA21 EMA50 EMA200
0.530.660.790.911.042026-092026-092026-092026-092026-092026-10
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin
-$11M-$5M$1M$7M$13M-95%-4%87%2025-Q22025-Q32025-Q42026-Q12026-Q2